OKUR vs SNPS · P/E 72, rev $2.0M vs P/E 63, rev $7.16B
OnKure Therapeutics, Inc. (OKUR) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
OKUR currently screens at market cap $76.6M and trailing P/E 71.8. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the OKUR and SNPS stock pages for the full models.
Not investment advice.